138 related articles for article (PubMed ID: 26152231)
21. Using ivermectin-treatment coverage among schoolchildren monitored by schoolteachers as a proxy of population coverage in areas of Uganda where onchocerciasis is endemic.
Ndyomugyenyi R; Remme J
Ann Trop Med Parasitol; 2002 Jan; 96(1):53-60. PubMed ID: 11989535
[TBL] [Abstract][Full Text] [Related]
22. Integrated community-directed treatment for the control of onchocerciasis, schistosomiasis and intestinal helminths infections in Uganda: advantages and disadvantages.
Ndyomugyenyi R; Kabatereine N
Trop Med Int Health; 2003 Nov; 8(11):997-1004. PubMed ID: 14629766
[TBL] [Abstract][Full Text] [Related]
23. Control of onchocerciasis in Nzerem-Ikpem, Nigeria: baseline prevalence and mass distribution of ivermectin.
Abanobi OC; Anosike JC
Public Health; 2000 Sep; 114(5):402-6. PubMed ID: 11035465
[TBL] [Abstract][Full Text] [Related]
24. Community-directed interventions strategy enhances efficient and effective integration of health care delivery and development activities in rural disadvantaged communities of Uganda.
Katabarwa MN; Habomugisha P; Richards FO; Hopkins D
Trop Med Int Health; 2005 Apr; 10(4):312-21. PubMed ID: 15807794
[TBL] [Abstract][Full Text] [Related]
25. Gender issues in the community-directed treatment with ivermectin (CDTI) of the African Programme for Onchocerciasis Control (APOC).
Clemmons L; Amazigo UV; Bissek AC; Noma M; Oyene U; Ekpo U; Msuya-Mpanju J; Katenga S; Sékétéli A
Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S59-74. PubMed ID: 12081252
[TBL] [Abstract][Full Text] [Related]
26. Onchocerciasis control in Nigeria: will households be able to afford community-directed treatment with ivermectin?
Onwujekwe O; Shu E; Onwuameze O; Ndum C; Okonkwo P
Acta Trop; 2001 Dec; 80(3):277-81. PubMed ID: 11700186
[TBL] [Abstract][Full Text] [Related]
27. Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin.
Shu EN; Nwadike KI; Onwujekwe EO; Ugwu OC; Okonkwo PO
East Afr Med J; 1999 Jun; 76(6):320-3. PubMed ID: 10750518
[TBL] [Abstract][Full Text] [Related]
28. Involvement of women in community-directed treatment with ivermectin for the control of onchocerciasis in Rukungiri district, Uganda: a knowledge, attitude and practice study.
Katabarwa MN; Habomugisha P; Ndyomugyenyi R; Agunyo S
Ann Trop Med Parasitol; 2001 Jul; 95(5):485-94. PubMed ID: 11487370
[TBL] [Abstract][Full Text] [Related]
29. Monitoring community-directed treatment programmes for sustainability: lessons from the African Programme for Onchocerciasis Control (APOC).
Amazigo UV; Obono M; Dadzie KY; Remme J; Jiya J; Ndyomugyenyi R; Roungou JB; Noma M; Sékétéli A
Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S75-92. PubMed ID: 12081253
[TBL] [Abstract][Full Text] [Related]
30. The African Programme for Onchocerciasis Control (APOC).
Amazigo U
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():19-22. PubMed ID: 18718149
[TBL] [Abstract][Full Text] [Related]
31. Assessment of the performance of community-directed treatment with ivermectin strategy for the control and elimination of onchocerciasis in Edo State, Nigeria.
Onowhakpor AO; Okojie OH; Wagbatsoma VA
Indian J Public Health; 2017; 61(4):267-273. PubMed ID: 29219132
[TBL] [Abstract][Full Text] [Related]
32. Community-directed, ivermectin-treatment programmes for onchocerciasis control in Uganda: the selection and validation of indicators for monitoring sustainability at the district level.
Katabarwa MN; Mutabazi D
Ann Trop Med Parasitol; 1999 Sep; 93(6):653-8. PubMed ID: 10707110
[TBL] [Abstract][Full Text] [Related]
33. Predictors for compliance with community directed ivermectin treatment in Bushenyi district of Uganda: qualitative results.
Nuwaha F; Okware J; Ndyomugyenyi R
East Afr Med J; 2004 Feb; 81(2):92-6. PubMed ID: 15125093
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Reported and Survey-Based Coverage in Onchocerciasis Programs over a Period of 8 Years in Cameroon and Uganda.
Katabarwa MN; Griswold E; Habomugisha P; Eyamba A; Byamukama E; Nwane P; Khainza A; Bernard L; Weiss P; Richards FO
Am J Trop Med Hyg; 2019 May; 100(5):1208-1215. PubMed ID: 30915956
[TBL] [Abstract][Full Text] [Related]
35. Onchocerciasis control in the Democratic Republic of Congo (DRC): challenges in a post-war environment.
Makenga Bof JC; Maketa V; Bakajika DK; Ntumba F; Mpunga D; Murdoch ME; Hopkins A; Noma MM; Zouré H; Tekle AH; Katabarwa MN; Lutumba P
Trop Med Int Health; 2015 Jan; 20(1):48-62. PubMed ID: 25302560
[TBL] [Abstract][Full Text] [Related]
36. Onchocerciasis in Anambra State, Southeast Nigeria: clinical and psychological aspects and sustainability of community directed treatment with ivermectin (CDTI).
Mbanefo EC; Eneanya CI; Nwaorgu OC; Oguoma VM; Otiji MO; Ogolo BA
Postgrad Med J; 2010 Oct; 86(1020):573-7. PubMed ID: 20971709
[TBL] [Abstract][Full Text] [Related]
37. In rural Ugandan communities the traditional kinship/clan system is vital to the success and sustainment of the African Programme for Onchocerciasis Control.
Katabarwa NM; Richards FO; Ndyomugyenyi R
Ann Trop Med Parasitol; 2000 Jul; 94(5):485-95. PubMed ID: 10983561
[TBL] [Abstract][Full Text] [Related]
38. Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria.
Brieger WR; Okeibunor JC; Abiose AO; Wanji S; Elhassan E; Ndyomugyenyi R; Amazigo UV
Parasit Vectors; 2011 Jul; 4():152. PubMed ID: 21794139
[TBL] [Abstract][Full Text] [Related]
39. Factors affecting community participation in the CDTI program in Morogoro, Tanzania.
York KJ; Kabole I; Mrisho M; Berry DM; Schmidt E
J Nurs Scholarsh; 2015 Jan; 47(1):96-104. PubMed ID: 25565278
[TBL] [Abstract][Full Text] [Related]
40. APOC's strategy of community-directed treatment with ivermectin (CDTI) and its potential for providing additional health services to the poorest populations. African Programme for Onchocerciasis Control.
Homeida M; Braide E; Elhassan E; Amazigo UV; Liese B; Benton B; Noma M; Etya'alé D; Dadzie KY; Kale OO; Sékétéli A
Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S93-104. PubMed ID: 12081254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
